SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

S4 - Movement Disorders: Beyond Oral Levodopa in Parkinson's Disease

Event Time: Sunday April 23, 2017 1:00 pm to 3:00 pm
Topic(s): Movement Disorders
Director(s):
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
2:35 PM - 3:00 PM Discussion Hubert Fernandez MD, FAAN 

Disclosures

Speaker Disclosure
Hubert H. Fernandez, MD, FAAN Dr. Fernandez has received honoraria from Prime Education Inc, Carling Communications, Medscape, as a speaker in CME events. Dr. Fernandez has received honoraria from Biogen, GE Health Care, Lundbeck, Merz Pharmaceuticals and Pfizer Pharmaceuticals, as a consultant.. Dr. Fernandez has received a stipend from International Parkinson and Movement Disorders Society for serving as Medical Editor of the MDS Web Site. . Dr. Fernandez has received royalty payments from Demos Publishing for serving as a book author/editor. Dr. Fernandez has received research support from Abbvie, Acadia, Auspex/Teva, Biotie/Acorda Therapeutics, Civitas, Kyowa/Prostrakan, Michael J. Fox Foundation, Movement Disorders Society, NIH/NINDS, Parkinson Study Group, Rhythm, Synosia, but has no owner interest in any pharmaceutical company. NIH/NINDS, Parkinson Study Group, Rhythm, Synosia, Teva, but has no owner interest in any pharmaceutical company. .

Abstract Presenters

Start Time Pub. Title Presenter
1:00 PM 001 Global long-term registry on efficacy and safety of levodopa-carbidopa intestinal gel in advanced Parkinson’s disease patients (GLORIA) – final results in a subgroup of patients with dyskinesia at baseline Werner Poewe, MD
Disclosure:
Dr. Bergmann has received personal compensation for activities with AbbVie as an employee. Dr. Bergmann holds stocks and stock options in AbbVie, which sponsored research in which Dr. Bergmann was involved as an investigator.

1:12 PM 002 ND0612, a novel liquid formulation of levodopa/carbidopa for subcutaneous infusion in patients with Parkinson’s disease achieves stable levodopa plasma levels when administered in low and high doses Nir Giladi, MD, FAAN
Disclosure:
Dr. Giladi has received personal compensation for activities with Teva-Lundbeck, Merz Inc., and UCB for activities with the Advisory Boards . f Teva-Lundbeck, Merz Inc. Dr. Giladi has received personal compensation for activities with Teva Israel, Intec Pharma and NeuroDerm Inc. as a consultant.

1:36 PM 004 Preliminary Results of the Phase I Clinical Study Evaluating Neural Stem Cell Based Therapy for Parkinson's Disease Russell Kern, PhD
Disclosure:
Dr. Kern has received personal compensation as an employee of International Stem Cell Corporation. Dr. Kern holds stock and/or stock options from International Stem Cell Corporation.

1:48 PM 005 Quality of Life in Homebound People with Advanced Parkinson′s Disease: Feasibility and Outcomes of an Interdisciplinary Home Visit Program Jori Fleisher, MD, MSCE
Disclosure:
Dr. Fleisher has nothing to disclose.

2:00 PM 006 Effects of a Parkinson-Specific, Interdisciplinary Approach, To Inpatient Rehabilitation Christian Benedict
Disclosure:
Dr. Benedict has nothing to disclose.

2:12 PM 007 Motor retraining (MoRe) for functional movement disorders: Outcomes from a one-week multidisciplinary rehabilitation program Alexandra Jacob
Disclosure:
Dr. Jacob has nothing to disclose.

2:24 PM 008 Outcomes of a Prospective, Multicenter International Registry of Deep Brain Stimulation for Parkinson's Disease Günther Deuschl
Disclosure:
Almirall, Boston Scientific and Desitin. Editor,Thieme Publishers. Medtronic: Post-study follow-up of the Earlystim study. Boston Scientific: Vercise registry.

Register Now

Related Courses

Saturday April 21, 2018

7:00 AM-9:00 AM
C4 Hyperkinetic Movement Disorders: Videodiagnosis and Treatment Steven Frucht MD
9:30 AM-11:30 AM
C14 Parkinson's Disease Update Melissa Nirenberg MD, PhD, FAAN
1:30 PM-3:30 PM
C23 Diagnosis and Treatment of Functional Movement Disorders Mark Hallett MD, FAAN

Sunday April 22, 2018

7:00 AM-9:00 AM
C24 Hot Topics and Controversies in Parkinson's Disease Melissa Nirenberg MD, PhD, FAAN
1:00 PM-3:00 PM
C36 Nonmotor Manifestations of Parkinson's Disease I Charles Adler MD, PhD, FAAN
3:30 PM-5:30 PM
C50 Nonmotor Manifestations of Parkinson's Disease II Charles Adler MD, PhD, FAAN

Monday April 23, 2018

7:00 AM-9:00 AM
C65 Video EEG: Name That Spell Amy Crepeau MD
C58 Balance and Gait Disorders Bastiaan Bloem MD, PhD
1:00 PM-3:00 PM
C67 Evaluating Tremor in the Office Vicki Shanker MD

Wednesday April 25, 2018

7:00 AM-9:00 AM
C140 Paroxysmal Movement Disorders Kailash Bhatia MD, FAAN
1:00 PM-5:30 PM
C159 Clinical Uses of Botulinum Toxin for Dystonia Skills Workshop Diego Torres-Russotto MD, FAAN

Thursday April 26, 2018

7:00 AM-9:00 AM
C176 The Dystonia: Diagnosis, Treatment and Update on Etiologies Rachel Saunders-Pullman MD
1:00 PM-3:00 PM
C187 Cerebellar and Afferent Ataxias: Diagnosis and Management Massimo Pandolfo MD, FAAN
3:30 PM-5:30 PM
C209 Clinical Usefulness of Botulinum Toxin for Spasticity Skills Workshop Allison Brashear MD, MBA, FAAN
6:30 PM-9:30 PM
C213 Case Studies: Unusual Movement Disorders Kailash Bhatia MD, FAAN

MEMBER LOG IN

Forgot Password?